Literature DB >> 31442367

Mind the Gap: Statin Underutilization and Impact on Mortality in Liver Transplant Recipients.

Patrick T Campbell1, Lisa B VanWagner1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31442367      PMCID: PMC6754301          DOI: 10.1002/lt.25627

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  12 in total

1.  Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.

Authors:  K D S Watt; R A Pedersen; W K Kremers; J K Heimbach; M R Charlton
Journal:  Am J Transplant       Date:  2010-05-10       Impact factor: 8.086

2.  Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.

Authors:  Sanjaya K Satapathy; Jason M Vanatta; Ryan A Helmick; Albert Flowers; Satish K Kedia; Yu Jiang; Bilal Ali; James Eason; Satheesh P Nair; Uzoma N Ibebuogu
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

3.  Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus.

Authors:  W P D Lemahieu; M Hermann; A Asberg; K Verbeke; H Holdaas; Y Vanrenterghem; B D Maes
Journal:  Am J Transplant       Date:  2005-09       Impact factor: 8.086

4.  High early cardiovascular mortality after liver transplantation.

Authors:  Lisa B VanWagner; Brittany Lapin; Josh Levitsky; John T Wilkins; Michael M Abecassis; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Liver Transpl       Date:  2014-10-24       Impact factor: 5.799

5.  Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.

Authors:  Ido Laish; Marius Braun; Eytan Mor; Jaqueline Sulkes; Yael Harif; Ziv Ben Ari
Journal:  Liver Transpl       Date:  2011-01       Impact factor: 5.799

Review 6.  Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Roger Chou; Tracy Dana; Ian Blazina; Monica Daeges; Thomas L Jeanne
Journal:  JAMA       Date:  2016-11-15       Impact factor: 56.272

7.  Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation.

Authors:  J Parekh; D A Corley; S Feng
Journal:  Am J Transplant       Date:  2012-04-30       Impact factor: 8.086

8.  The impact of coronary artery disease on outcomes after liver transplantation.

Authors:  Anton I Skaro; Lorenzo G Gallon; Vadim Lyuksemburg; Colleen L Jay; Lihui Zhao; Daniela P Ladner; Lisa B VanWagner; Andre M De Wolf; James D Flaherty; Josh Levitsky; Michael M Abecassis; Mihai Gheorghiade
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2016-12       Impact factor: 2.160

9.  Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.

Authors:  L B VanWagner; M Serper; R Kang; J Levitsky; S Hohmann; M Abecassis; A Skaro; D M Lloyd-Jones
Journal:  Am J Transplant       Date:  2016-03-29       Impact factor: 8.086

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  1 in total

Review 1.  Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

Authors:  Blessing Aghaulor; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2020-10-26       Impact factor: 6.126

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.